Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-12-01T02:29:54.818Z Has data issue: false hasContentIssue false
  • English
  • Français

Anaerobic Bacteremia in Patients with Acute Leukemia

Published online by Cambridge University Press:  21 June 2016

Elizabeth A. Brown ,
George H. Talbot ,
Mary Provencher  and
Peter Cassileth
Elizabeth A. Brown
Affiliation:
Infectious Diseases and Hematology-Oucology Sections, Department of Medicine, University of Pennsylvania, School of Medicine and the Infection Control Section, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
George H. Talbot*
Affiliation:
Infectious Diseases and Hematology-Oucology Sections, Department of Medicine, University of Pennsylvania, School of Medicine and the Infection Control Section, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
Mary Provencher
Affiliation:
Infectious Diseases and Hematology-Oucology Sections, Department of Medicine, University of Pennsylvania, School of Medicine and the Infection Control Section, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
Peter Cassileth
Affiliation:
Infectious Diseases and Hematology-Oucology Sections, Department of Medicine, University of Pennsylvania, School of Medicine and the Infection Control Section, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
*
Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104
Get access Rights & Permissions [Opens in a new window]

Abstract

We reviewed 402 hospital admissions of patients with acute leukemia to define the frequency and characteristics of anaerobic bacteremia in this patient population. Six (5.2%) of the 116 septicemia episodes documented in these patients were caused by anaerobes (Bacteroides species, 3; Fusobacterium species, 2; and Clostridium tertium, 1); two of these episodes were polymicrobial. Five patients had had prior bacteremia. All six patients were receiving broad-spectrum antibiotics, including an anti-pseu-domonal penicillin, at the time of the episode. In each instance, the absolute granulocyte count was 0/mm3. Five patients had clinically apparent sources of infection, including perirectal abscess, gastrointestinal bleeding, or Clostridium difficile- associated diarrhea. Anaerobic bacteremia is an infrequent occurrence in granulocytopenic patients with acute leukemia, but may occur when there is obvious disruption of normal gastrointestinal anatomic barriers.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 10 , Issue 2 , February 1989 , pp. 65 - 69
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1989

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Alpern, RJ, Dowell, VR: Clostridium septicum infections and malignancy. JAMA 1969; 209:385–388.Google Scholar
2. Koransky, JR, Stargel, MD, Dowell, VR: Clostridium septicum bacteremia: Its clinical significance. Am J Med 1979: 66:63–66.Google Scholar
3. Thaler, M, Gill, V, Pizzo, PA: Emergence of Clostridium tertium as a pathogen in neutropenic patients. Am J Med 1986; 81:596–600.Google Scholar
4. Bodey, GP, Rodriguez, V, Chang, HY. et al: Feyer and infection in leuke mic patients: A study of 494 consecutive patients. Cancer 1978; 41:1610–1622.Google Scholar
5. Silver, RT, Utz, JP, Frei, E. et al: Feyer. infection and host resistance in acute leukemia. Am J Med 1958; 24:25–39.Google Scholar
6. Tobias, JS, Wrigley, PFM, O'Grady, F: Bacterial infection and acute myeloblastic leukemia: An analysis of two hundred patients undergoing intensive remission induction therapy. Europ J Coucer 1978; 14: 383–391.Google Scholar
7. Nachman, JB, Honig, GR: Feyer and neutropenia in children with neoplastic disease: An analysis of 158 episodes. Cancer 1980; 15:407–412.10.1002/1097-0142(19800115)45:2<407::AID-CNCR2820450237>3.0.CO;2-SGoogle Scholar
8. Pizzo, PA, Hathorn, JW, Heimenz, J. et al: A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with feyer and neutropenia. J Engl J Med 1986; 315:552–558.Google Scholar
9. Whimbey, E, Kiehn, TE, Brannon, P. et al: Bacterenia and fungemia in patients with neoplastic disease. Am J Med 1987: 82:723–730.CrossRefGoogle ScholarPubMed
10. Singer, C, Kaplan, MH, Armstrong, D: Bacteremia and fungemia complicating neoplastic disease: A study of 364 cases. Am J Med 1977; 62:734–742.Google Scholar
11. Stuart, RK, Braine, HG, Lietman, PS. et al: Carbenicillin-trimethoprim/sulfamethoxazole versus carbenicillin-gentamicin as empiric therapy of infection in granulocytopenic patients: A prospective, randomized, double-blind study. Am J Med 1980; 68:876–885.Google Scholar
12. Kramer, BS, Ramphal, R, Rand, KH: Randomized comparison between two cettazidime-containing regimens and cephalothin-gentamicin-carbenicillim in febrile granulocytopenic cancer patients. Antimicrob Agents Chemother 1986; 30:64–68.Google Scholar
13. Winston, DJ, Ho, WG, Young, LS, et al: Piperacillin plus amikacin therapy v. carbenicillin plus amikacin therapy in febrile, granulocytopenic patients. Arch Inteyn Med 1982; 142:1163–1167.Google Scholar
14. Bodey, GP, Nies, BA, Freireich, FJ: Multiple organism septicemia in acute leukemia: Analysis of 54 episodes. Arch Intern Med 1965: 116:266–272. Google Scholar
15. Elting, LS, Bodey, GP, Fainstein, V: Polymicrobial septicemia in the cancer patient. Medicine 1986; 65:218–225.CrossRefGoogle ScholarPubMed
16. Abrutyn, E, Talbot, GH: Surveillance strategies: A primer, Infect Control 1987; 8:459–464.Google Scholar
17. Finegold, SM: Amacrobic Bacteria in Human Disease. New York. Academic Press. 1977. pp 182–201.Google Scholar
18. Fellner, JM, Dowell, VR: “Bacteroides’ bacteremia. Am J Med 1971: 50:787–796.10.1016/0002-9343(71)90187-2Google Scholar
19. Willis, AF: Host factors predisposing to anaerobic infections. Scand J Defect Dis 1985; 46(suppl): 18–26.Google Scholar
20. Kasper, DL, Onderdonk, AB, Crabb, J, et al: Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis , J Infect Dis 1979; 140:724–731.Google Scholar
21. Onderdonk, AB, Markham, RB, Zaleznik, DF, et al: Evidence for T cell-dependent immunity to Bacteroides fragilis in an intra-abdominal abscess model. J Clin Invest 1982: 69:9–16.CrossRefGoogle Scholar
22. Simon, GL. Klempner, MS, Kasper, DL. et al: Alterations in opsonophagocytic killing by neutrophils of Bacteroides fragilis associated with animal and laboratory passage: Effect of capsular polysace haride. J Infect Dis 1982: 145:72–77.Google Scholar
23. Adamu, SA, Sperry, JF: Polymorphonuclear neutrophil Chemotaxis induced and inhibited by Bacteroides spp. Infect Immunol 1981: 33:806–810.Google Scholar
24. Rampling, A, Warren, RE, Beyan, PC. et al: Clostridium difficile in hematologic malignancy. J Clin Pathol 1985; 38:445–451.Google Scholar
25. Sutter, VL, Finegold, SM: Susceptibility of anaerobic bacteria to 23 antimicrobial agents. Antimicrob Agents Chemother 1970; 10:736–752.Google Scholar
26. Monif, GRG, Clark, PR, Shuster, JJ. et al: Susceptibility of the anaerobic bacteria. group D streptococci. Euterobacteriaceae and Pseudomouus to semisynthetic penicillins: Carbenicilliu. piperacillin, and ticancillin. Antimicrob Agents Chemother 1978; 14 643–649.10.1128/AAC.14.5.643Google Scholar
27. Marrie, TJ, Haldane, EV, Swantee, CA. et al: Susceptibility of anaerobic bacteria to nine antimicrobial agents and demonstration of decreased susceptibility of Clostridium perfringens to penicillin. Antimarob Agents Chemother 1981; 19:51–55.10.1128/AAC.19.1.51Google Scholar
28. Sorrell, TC, Marshall, JR, Chow, AW: Antimicrobial therapy of postpartum endomyometritis I. Comparative susceptibility of mezlocillin and other antibiotics to genital anaerobic bacteria. Am J Obstet Gyuecol 1981; 141:242–245.Google Scholar
29. Bourgault, AM, Harding, GK, Smith, JA. et al: Survey of anaerobic susceptibility patterns in Canada. Antimicrob Agents Chemother 1986; 30:798–801.CrossRefGoogle ScholarPubMed
30. Musher, DM: Streplococeus faecalis and other group D streptococci, in Mandell, GL, Douglas, RG, Bennett, JE (eds): Principles and Practice of Infectious Diseases. ed 2. New York, John Wiley and Sons. 1985. pp 1152–1155.Google Scholar